Puma Biotechnology, Inc.
PBYI· Nasdaq
Puma Biotechnology, Inc.
- Last sale
- Oct 1, 2026 · -0.96%
- Market cap
- $508.20M
- 51.62M shares
- Filings
- 1,017
Price
Oct 1, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $228,371,000 | reported | |
| FY 2024 | 2024-12-31 | $230,468,000 | reported | |
| FY 2023 | 2023-12-31 | $235,637,000 | reported | |
| FY 2022 | 2022-12-31 | $228,031,000 | reported | |
| FY 2021 | 2021-12-31 | $253,155,000 | reported | |
| FY 2020 | 2020-12-31 | $225,110,000 | reported | |
| FY 2019 | 2019-12-31 | $272,260,000 | reported | |
| FY 2018 | 2018-12-31 | $250,991,000 | reported | |
| FY 2017 | 2017-12-31 | $27,685,000 | reported |
Puma Biotechnology, Inc. · CIK 1401667 · Engraved from SEC EDGAR
